ReviewActa Pharm Sin B2021
New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors.
- Journal
- Acta Pharm Sin B
- Published
- 31 October 2020
- Citations
- 46
- Type
- Review
- License
- cc by-nc-nd
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by-nc-nd
As one of the most lethal diseases, pancreatic cancer shows a dismal overall prognosis and high resistance to most treatment modalities. Furthermore, pancreatic cancer escapes early detection during the curable period because early symptoms rarely emerge and specific markers for this disease have not been found. … Excerpt only: this text is the publisher’s. Read it in full at the source.